| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.lasalabs.com | |
| Market Cap | 128.46 Cr. | |
| Enterprise Value(EV) | 127.74 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -4.28 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 41.93 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 22.33 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 1.15 | Calculated using Price: 25.64 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 5.01 Cr. | 50,101,239 Shares |
| FaceValue | 10 | |
| About Lasa Supergenerics Ltd. | ||
| The company is specialises in ‘catalyst chemistry' and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in India | ||
| 1 Day |
|
-0.62% |
| 1 Week |
|
-1.13% |
| 1 Month |
|
+15.93% |
| 3 Month |
|
-20.56% |
| 6 Month |
|
+1.19% |
| 1 Year |
|
+2.83% |
| 2 Year |
|
-55.12% |
| 5 Year |
|
-1.85% |
| 10 Year |
|
| 8 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 0 | 8.65 | 14.33 | -10.81 | 2.94 | 15.17 | -3.37 | -27.97 | |
| Return on Capital Employed (%) | 0 | 14.45 | 12.8 | -3.73 | 6.77 | 17.14 | -3.41 | -23.94 | |
| Return on Assets (%) | 0 | 2.07 | 4.79 | -4.44 | 1.5 | 10.43 | -2.56 | -20.71 |
| Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 0 | 75 | 117 | 105 | 141 | 159 | 158 | 118 | 113 | |
| Non Curr. Liab. | 0 | 83 | 62 | 43 | 11 | 8 | 7 | 3 | 7 | |
| Curr. Liab. | 70 | 107 | 107 | 76 | 41 | 45 | 43 | 46 | ||
| Minority Int. | ||||||||||
| Equity & Liab. | 0 | 228 | 287 | 255 | 229 | 208 | 209 | 164 | 166 | |
| Non Curr. Assets | 149 | 178 | 170 | 153 | 144 | 143 | 125 | 120 | ||
| Curr. Assets | 0 | 79 | 109 | 86 | 76 | 64 | 66 | 39 | 45 | |
| Misc. Exp. not W/O | 0 | |||||||||
| Total Assets | 0 | 228 | 287 | 255 | 229 | 208 | 209 | 164 | 166 |
| Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 199 | 244 | 170 | 167 | 202 | 137 | 130 | 117 | ||
| Other Income | 2 | 3 | 1 | 0 | 0 | 0 | 2 | 1 | ||
| Total Income | 201 | 247 | 170 | 167 | 203 | 137 | 131 | 118 | ||
| Total Expenditure | -153 | -202 | -159 | -137 | -155 | -121 | -136 | -106 | ||
| PBIDT | 48 | 45 | 12 | 30 | 47 | 16 | -5 | 12 | ||
| Interest | -12 | -11 | -8 | -8 | -2 | 0 | -4 | -2 | ||
| Depreciation | -8 | -18 | -19 | -17 | -16 | -15 | -13 | -12 | ||
| Taxation | 0 | -3 | 4 | -1 | -7 | 1 | 4 | 1 | ||
| Exceptional Items | -26 | -8 | -20 | -20 | ||||||
| PAT | 2 | 12 | -12 | 4 | 23 | -5 | -39 | -21 | ||
| Adjusted EPS | 472 | 5 | -5 | 1 | 6 | -1 | -8 | -4 |
| Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | -3 | 40 | 41 | 14 | 41 | 9 | -17 | |
| Cash Fr. Inv. | 0 | -44 | -7 | -2 | -4 | -3 | 11 | ||
| Cash Fr. Finan. | 0 | 0 | 4 | -33 | -10 | -36 | 0 | -4 | |
| Net Change | 0 | -3 | 0 | 0 | 2 | 1 | 6 | -10 | |
| Cash & Cash Eqvt | 0 | 0 | 1 | 0 | 3 | 4 | 11 | 1 |
|
Tue, 30 Apr 2024
Declaration With Respect To Non -Applicability Of Large Entities Framework Pursuant To SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November 2018 Pursuant to circular No SEBI/HO/DDHS/CIP/P/2018/144 dated 26th November 2018 for fund raising by issuances of debt Securities by large entities and Compliance thereofwe hereby submit that our company is out of the purview of Large Corporate category as per the applicability of framework provided in the aforesaid Circular |
|
Mon, 29 Apr 2024
YEARLY CERTIFICATE FROM PRACTICING COMPANY SECRETARY UNDER REG 40(9) OF SEBI (LODR) REGULATIONS 2015 Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulation 2015 We are enclosing herewith the certificate from Shivam Sharma and Associates Practicing Company Secretaries for the year ended 31st March 2024 |
|
Fri, 26 Apr 2024
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) Mr.Ravi Shankar kabra CFO of the company tendered his resignation vide letter dated April 25 2024 due to health reasons and other pre occupations he will be relieved of his duties effective end of business hours of April 26 2024 |
| Tue, 30 Apr 2024 |
Higher Delivery Quantity
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Opening at Low
|
Making Lower Lows for 2 Days
|
